Enzene - We are a global CDMO and biosimilar developer dedicated to realizing your vision to bring accessible, high-quality treatments to patients around the world.
- NeX™: Our Factory or Yours. Local Biomanufacturing, Made Possible.
- Manufacturing innovation that can make biologics more affordable for patients worldwide.
- We are proud to be GPTW certified
- 5 Years in a row
- Winner of 2025 CPHI Pharma Award for Manufacturing Excellence
- Making $40/gram possible.
- Biologics innovation begins with Enzene.
- The new face of CIDMO is Enzene.
- A Continuously Innovative Development & Manufacturing Organization
Problems we solve
With years of technical expertise and a platform that pushes your projects further, your progress is our priority.
Licensing
Who is Enzene?
We are a global CDMO dedicated to impacting
the global healthcare landscape by bringing
trusted and affordable medicines to market, quickly.
Committed to innovation, we have revolutionized biologics production with our patented and validated continuous bioprocess manufacturing platform, EnzeneX®, that enables us to significantly reduce the cost of producing complex biologics and monoclonal antibodies (mAbs).
Our fully-integrated services and productive pipeline of biosimilars are designed to cater to your project’s every need.
Biosimilars: A comparability study
A customer approached Enzene to complete comparability testing, focusing on the comparison of the physiochemical and biological properties of a biosimilar monoclonal antibody (mAb) drug product to the reference medicinal product (RMP). Find out how we helped them achieve success.
The most advanced innovation is only one step away.
From discovery to commercial supply, an Enzene partnership brings a new way of thinking about biologics.
Let’s discuss your challenge or project.